Close
Search for:
Search Button
Skip to primary navigation
Skip to main content
Skip to footer
Be Biopharma
Advancing our science with bold humanity
Investors & Media
News Releases
Publications & Presentations
Careers
Contact Us
Search
Our Company
Life at Be Bio
Our Science
Our Platform
Publications & Presentations
Patients & Caregivers
Home
/
In the News
/
Second engineered B cell therapy enters the clinic, promising to do in hemophilia B what gene therapies can’t
Second engineered B cell therapy enters the clinic, promising to do in hemophilia B what gene therapies can’t
Our Company
Life at Be Bio
Our Science
Our Platform
Publications & Presentations
Patients & Caregivers
Investors & Media
News Releases
Publications & Presentations
Careers
Contact Us
